Loading...
Precision Medicine And Aging Markets Will Fuel Oncology Despite Setbacks
AnalystHighTarget's Fair Value
US$7.00
76.6% undervalued intrinsic discount11 Sep
US$1.64
1Y
60.8%7D
5.1%1Y
60.8%7D
5.1%You can edit this narrative until Aug 11 9:23 PM. Then, changes will post as Updates.